AMGEN Inc
NASDAQ: AMGN
$293.54
-$4.24 (-1.4%)
Closing Price on February 7, 2025
AMGN Articles
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down...
Published:
These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street this Wednesday morning with more than two hours until the market opens: Alcatel-Lucent...
Published:
These are among the top research calls and analyst upgrades and downgrades we have seen early this Friday morning with over two hours until the open: Amgen (AMGN) Raised to Outperform at Baird....
Published:
Amgen Inc. (NASDAQ: AMGN) has posted some very highly anticipated and uninteresting earnings. The biotech giant reported $0.98 EPS net and $1.08 non-GAAP EPS on $3.31 billion in revenue, while...
Published:
Last Updated:
This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual...
Published:
These are ten of the top impact research calls with upgrades and downgrades from Wall Street early this Friday morning: Amgen (AMGN) Raised to Overweight at JPMorgan. ConocoPhillips (COP) Raised to...
Published:
Layoffs at big companies are so common now that it is novel when a day goes by without Microsoft (MSFT), Caterpillar (CAT), or Macy’s (MC) letting thousands of people go. There are a relatively...
Published:
Last Updated:
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show that this...
Published:
Last Updated:
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT reported that the world’s largest pharmaceutical company is willing to...
Published:
Last Updated:
It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally you see a pattern. This month the only pattern seems to be one...
Published:
Today 24/7 Wall St.named its annual CEO of the Year James A. Skinner of McDonald’s (MCD). He was picked from a field of ten executives which we profiled over the last ten days. Skinner was chosen...
Published:
Last Updated:
24/7 Wall St. will name its annual CEO of the Year next week. The executive will be picked from a field of ten which we will profile this week The CEOs are chosen on the basis of their company’s...
Published:
Amgen Inc. (NASDAQ: AMGN) has just posted earnings. The biotech giant for anemia treatments posted $1.09 GAAP EPS and adjusted earnings of $1.23 non-GAAP EPS and $3.875 billion in revenues. First...
Published:
Last Updated:
These are some of the top upgrades we are seeing from Wall Street analysts this morning: Amgen (AMGN) Raised to Outperform at William Blair. Capital Product Partners (CPLP) Started as Outperform at...
Published:
According to Reuters, the federal government bailed out AIG (AIG) The Fed will loan the insurance company $85 billion for two years in exchange for a 79.9% stake. Reuters says that Barclays (BCS)...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.